“The compound SR-17018 is the first biased agonist from the mu opioid receptor that does not lead to tolerance with Persistent use,” says Stahl, a senior staff scientist within the Bohn lab. “This is a fascinating attribute for prospective use within the context of chronic, intense soreness.” Don’t miss out on a eureka second! Get